Cigarette smoking is associated with acrylamide exposure among the U.S. population: NHANES 2011-2016

Abstract

2-carbamoylethyl mercapturic acid (2CaEMA, N-Acetyl-S-carbamoylethyl-L-cysteine) is a urinary metabolite and exposure biomarker of acrylamide, which is a harmful volatile organic compound found in cigarette smoke and in some foods. The goal of this study was to determine the association between cigarette smoking and urinary 2CaEMA concentrations among the U.S. population while considering potential dietary sources of acrylamide intake and demographics. We measured 2CaEMA concentrations in urine specimens collected during the National Health and Nutrition Examination Survey 2011-2012, 2013-2014, and 2015-2016 cycles from eligible participants 18 years and older (n = 5443) using liquid chromatography/tandem mass spectrometry. We developed multiple regression models with urinary 2CaEMA concentrations as the dependent variable and sex, age, race/Hispanic origin, reported primary sources of dietary acrylamide intake, and cigarette smoke exposure as independent variables. This study demonstrates that cigarette smoking is strongly associated with urinary 2CaEMA, suggests that cigarette smoking is likely a primary source of acrylamide exposure, and provides a baseline measure for 2CaEMA in the U.S. population.

Keywords: 2-Carbamoylethyl mercapturic acid (2CaEMA); AAMA; Acrylamide; GAMA; The national health and nutrition examination survey (NHANES); Tobacco smoke.

Fig. 1.

Geometric least-squares means of urinary 2CaEMA (ng/mL) among NHANES 2011–2016 participants stratified by tobacco smoke exposure categories (n = 5443). 1. Significantly different compared to unexposed participants. 2. Significantly different compared to participants exposed to SHS. 3. Significantly different compared to participants who smoked 1–9 CPD. 4. Significantly different compared to participants who smoked 10–19 CPD. CPD, cigarettes per day SHS, secondhand smoke